Moreover, the degradation assay results revealed that the half-life of exogenously expressed Drp1 was significantly decreased in ROCK2-overexpressing CCA cells compared to that in control cells (Fig. S11D, E). The gene discussed is ROCK2; the disease is cholangiocarcinoma.